Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zyus Life Sciences Corporation (ZYUS.VN)

Zyus Life Sciences Corporation (ZYUS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 53,648
  • Shares Outstanding, K 80,072
  • Annual Sales, $ 481 K
  • Annual Income, $ -33,805 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 108.90
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.46
  • Most Recent Earnings $-0.05 on 11/26/25
  • Next Earnings Date 05/06/25
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING:

    TSX Drug Specialty & Generic

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.07
  • Number of Estimates 1
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -133.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.600 +11.67%
on 12/29/25
0.700 -4.29%
on 01/12/26
-0.030 (-4.29%)
since 12/16/25
3-Month
0.600 +11.67%
on 12/29/25
0.700 -4.29%
on 01/12/26
-0.020 (-2.90%)
since 10/14/25
52-Week
0.550 +21.82%
on 05/20/25
0.890 -24.72%
on 01/27/25
-0.170 (-20.24%)
since 01/16/25

Most Recent Stories

More News
ZYUS Life Sciences Announces LIFE Offering of a minimum of C$15 Million and maximum of C$16 Million of Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan, Jan. 12, 2026 (GLOBE NEWSWIRE) -- ZYUS Life Sciences Corporation (the " Company ")...

ZYUS.VN : 0.670 (+1.52%)
ZYUS Life Sciences Reports Preliminary Results from Ongoing Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug

Early Data Suggests a Trend Toward Improvement in Pain Efficacy

ZYUS.VN : 0.670 (+1.52%)
ZYUS Life Sciences Reports Preliminary Results from Ongoing Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug

Early Data Suggests a Trend Toward Improvement in Pain Efficacy

ZYUS.VN : 0.670 (+1.52%)
ZYUS Life Sciences Announces Activation of Two Additional Clinical Sites in Phase 2a UTOPIA-1 Cancer Pain Trial

Expansion to three active C anadian sites marks a key milestone in advancing Trichomylin® softgel capsules into later-stage trials

ZYUS.VN : 0.670 (+1.52%)
ZYUS Life Sciences Announces Activation of Two Additional Clinical Sites in Phase 2a UTOPIA-1 Cancer Pain Trial

/CNW/ - ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of...

ZYUS.VN : 0.670 (+1.52%)
ZYUS Life Sciences Activates First Clinical Site and Enrolls First Patient in Phase 2a UTOPIA-1 Cancer Pain Trial

Phase 2a trial designed to investigate the safety and preliminary analgesic efficacy of Trichomylin® softgel capsules

ZYUS.VN : 0.670 (+1.52%)
ZYUS Life Sciences Activates First Clinical Site and Enrolls First Patient in Phase 2a UTOPIA-1 Cancer Pain Trial

/CNW/ - ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of...

ZYUS.VN : 0.670 (+1.52%)
ZYUS Life Sciences Announces Closing of Second Tranche of Unit Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN   THE   UNITED   STATES/

ZYUS.VN : 0.670 (+1.52%)
ZYUS Life Sciences Announces Closing of Second Tranche of Unit Offering

/CNW/ - ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of...

ZYUS.VN : 0.670 (+1.52%)
ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /

ZYUS.VN : 0.670 (+1.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ZYUS Life Sciences Corp is primarily engaged in the world-wide development and commercialization of cannabinoid-based therapeutics and product candidates. It is a licensed producer and distributor of medical cannabis for both medical and adult recreational access in Canada. The company has one reportable...

See More

Key Turning Points

3rd Resistance Point 0.687
2nd Resistance Point 0.683
1st Resistance Point 0.677
Last Price 0.670
1st Support Level 0.667
2nd Support Level 0.663
3rd Support Level 0.657

See More

52-Week High 0.890
Fibonacci 61.8% 0.760
Fibonacci 50% 0.720
Fibonacci 38.2% 0.680
Last Price 0.670
52-Week Low 0.550

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar